- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05768295
Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants (Prospective_X3)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The total study duration for each patient should be 3 years after loading. .
The investigational devices are CE-(Conformité Européenne, meaning European Conformity) marked product.
14 centers will participate in France
Implants used are Axiom® BL X3 with lengths ranging from 6.5 to 18 mm and diameters ranging from 3.4 to 6.4 mm.
The study and any amendments will be performed as far as possible according to International Organization for Standardization (ISO) 14155, 21CFR 820 for FDA requirement and conform to the Declaration of Helsinki (last revision Fortaleza 2013) and local legal and regulatory requirements.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marie Chauvet
- Phone Number: +33 (0)4 50 58 02 37
- Email: marie.chauvet@anthogyr.com
Study Contact Backup
- Name: Nicolas Courtois
- Phone Number: +33 (0)4 50 58 02 37
- Email: nicolas.courtois@anthogyr.com
Study Locations
-
-
-
Annecy, France
- Recruiting
- Cabinet Dentaire Les Aravis
-
Principal Investigator:
- Nicolas Jung, Dr
-
Sub-Investigator:
- Jean-Luc Lescure, Dr
-
Beauvais, France
- Recruiting
- Cabinet Dr Fumery
-
Principal Investigator:
- Océan Fumery, Dr
-
Cadaujac, France
- Recruiting
- Cabinet Dr Vigouroux
-
Principal Investigator:
- François Vigouroux, Dr
-
Draguignan, France
- Recruiting
- Cabinet dentaire Octogone
-
Principal Investigator:
- Adrien Sette, Dr
-
Sub-Investigator:
- Julien Sette, Dr
-
L'Isle-sur-la-Sorgue, France
- Recruiting
- Cabinet dentaire La Bastide
-
Principal Investigator:
- Remy Latombe, Dr
-
Le Bouscat, France
- Recruiting
- Cabinet dentaire Dr Murcia
-
Principal Investigator:
- Jonathan Murcia, Dr
-
Marseille, France
- Recruiting
- Cabinet Dentaire Patrice Margossian
-
Principal Investigator:
- Patrice Margossian, Dr
-
Sub-Investigator:
- Emilie Goemaere, Dr
-
Moulins, France
- Recruiting
- Cabinet Dr Bruet
-
Principal Investigator:
- Pierre Bruet, Dr
-
Sallanches, France
- Recruiting
- Cabinet Dr Monnot
-
Principal Investigator:
- Chloé Monnot, Dr
-
Toulouse, France
- Recruiting
- Cabinet BAG
-
Principal Investigator:
- Philippe Boghanim, Dr
-
Villefranche-sur-Saône, France
- Recruiting
- Implantys
-
Principal Investigator:
- Harmik Minassian
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients must provide their informed consent for study participation and must be willing and able to attend control visit (in the standard of care)
- Patients must be males or females who are a minimum of 18 years of age
- Patients seeking an implant supported restoration
- Patient Affiliated to (or beneficiary of) the French Social Security
- Patients who do not present any contraindication for implant restoration, in accordance to IFU
Exclusion Criteria:
- Patients who have no follow-up visit planned with the investigator or co-investigators
- Patients with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance with study visit or unreliability
- A woman who is pregnant or planning to become pregnant at any point during the study duration
- Patients currently participating in another clinical research
- Patients who present contraindication for implant restoration, in accordance to IFU
- Adults under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Axiom BL X3
Dental implant Axiom BL X3
|
collecting data on the use of Axiom BL X3 and patient satisfaction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant success rate
Time Frame: 3 years after loading
|
The success rate will be assessed according to the criteria of Buser
|
3 years after loading
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant survival rate
Time Frame: 6, 12 months, and 3 years after loading
|
A surviving implant is an implant that is in place at the time of evaluation
|
6, 12 months, and 3 years after loading
|
Prosthesis survival rate
Time Frame: 6, 12 months, and 3 years after loading
|
a surviving prosthesis is a prosthesis that is not broken at the time of evaluation
|
6, 12 months, and 3 years after loading
|
Prosthesis success rate
Time Frame: 6, 12 months, and 3 years after loading
|
Success will be defined as the prosthesis that remained unchanged and did not require any intervention during the entire observational period.
|
6, 12 months, and 3 years after loading
|
Marginal bone level changes
Time Frame: 12 months and 3 years after loading
|
Change in crestal bone level measured by analysis of standardized peri-apical xrays [mm]
|
12 months and 3 years after loading
|
Patient Reported Outcome
Time Frame: 6, 12 months, and 3 years after loading
|
The local language version of the OHIP-14 is a self-reported questionnaire that measures dysfunction, discomfort and disability attributed to oral conditions.
The questionnaire focuses on seven dimensions of impact: Functional limitation; Pain; Psychological discomfort; Physical disability; Psychological disability; Social disability; Handicap.
The patients will be asked to respond according to frequency of impact on a 5-point Likert scale coded never (score 0), hardly ever (score 1), occasionally (score 2), fairly often (score 3) and very often (score 4).
|
6, 12 months, and 3 years after loading
|
Physician satisfaction of the implant stability
Time Frame: at the time of implant placement
|
Likert scale : The likert scale will be used for consistency and provides five possible answers to a statement or question that allows respondents to indicate their positive-to-negative strength of agreement or strength of feeling regarding the question or statement.
|
at the time of implant placement
|
Interim Implant success rate
Time Frame: 6, 12 months
|
A surviving implant is an implant that is in place at the time of evaluation
|
6, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Patrice Margossian, Dr, Cabinet Dr Margossian
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C2101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania
-
University of BelgradeCompleted
-
Kafrelsheikh UniversityRecruitingDental Implant Failed | Implant ComplicationEgypt
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
ORHUN EKRENCompletedDental Implant | Short Dental Implant
-
Cairo UniversityUnknownImplant Stability | Root Analog Implant | Conventional Root Form Implant | Non Restorabl Teeth
-
University of BarcelonaGeistlich Pharma AG; Adin ImplantsUnknownDental Implant | Guided Bone Regeneration | Narrow Implant | Implant FractureSpain
-
Cairo UniversityNot yet recruitingImmediate Loading , Satellite Implant , Immediate ImplantEgypt
-
Università degli Studi di SassariDr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaboratorsNot yet recruiting
-
Cairo UniversityNot yet recruitingDental Implant Failed | Implant Site Reaction
Clinical Trials on Axiom BL X3
-
AnthogyrActive, not recruitingEdentulous | Dental ImplantsSpain, Portugal
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
Stryker OrthopaedicsActive, not recruitingArthroplasty, Replacement, HipUnited States, Canada, Germany
-
CardioFocusCompletedAtrial FibrillationCzechia
-
CardioFocusCompletedAtrial FibrillationCzechia
-
Stryker Japan K.K.Completed
-
Stryker OrthopaedicsCompleted
-
University of AarhusEnrolling by invitationArthroplasties, Hip ReplacementDenmark
-
Stryker OrthopaedicsTerminatedArthroplasty, Replacement, KneeLuxembourg, Germany, United Kingdom